US 8716301
Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation
granted A61KA61K2039/55561A61K31/00
Quick answer
US patent 8716301 (Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue May 06 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 01 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K2039/55561, A61K31/00, A61K31/365, A61K31/519